Navigation Links
Inflammation in prostate may reduce cancer risk
Date:12/9/2013

MANHASSET, NY Doctors at the North Shore-LIJ Health System have discovered that increased inflammation in the prostate may predict reduced risk for prostate cancer. The findings are published online in CANCER.

Prostate cancer is one of the most common cancers in men, with an estimated 240,000 new cases diagnosed every year it kills approximately 30,000 men annually. The prostate is a small gland that produces fluid that nourishes and transports sperm. When the cancer is detected early while still confined to the prostate gland, there is a much better chance of successful treatment according to the American Cancer Society, a five-year relative survival rate is 100 percent when prostate cancer is detected early and there is no sign that the cancer has spread outside of the prostate.

Previous studies have found that chronic inflammation contributes to several forms of cancer an estimated 20 percent of adult cancers can be attributed to chronic inflammatory conditions. To evaluate if inflammation in the prostate increases the risk of cancer in the gland, Daniel Moreira, MD, a urologist at the North Shore-LIJ Health System, and his colleagues conducted a clinical trial.

They conducted a retrospective analysis of the REduction by DUtasteride of PCa Events (REDUCE) trial, including 6,238 men ages 50 to 75 who had increased prostate inflammation with a negative biopsy (no cancer). They then underwent two more biopsies one at two years and another at four years. At both two- and four-year intervals, the doctors found that those participating in the study who had higher levels of prostate inflammation also had a lower risk of prostate cancer. These findings show that biopsies in prostates that are free of cancer and have high inflammation may indicate a lower risk for getting prostate cancer in the future.

"Because we have shown that inflammation has a predictive value, it should be routinely evaluated in prostate biopsies," said Dr. Moreira. "Also, this research shows that patients showing inflammation at an initial biopsy may be evaluated by their physician differently from with patients without inflammation at an initial biopsy given their risk of subsequent cancer detection is lower."

At the conclusion of the CANCER article, Dr. Moreira and his colleagues discuss the concept of immunosurveillance when the immune system produces inflammation because it recognizes cancerous cells as threatening, foreign agents and eliminates them before they can become an established tumor. This concept of immunosurveillance may explain why inflammation led to a reduced risk of prostate cancer inflammation may correlate with immunosurveillance leading to the elimination of cancerous cell. Therefore, with ongoing studies and research in monitoring and moderating inflammation, new prevention and treatment methods for prostate cancer could be discovered.


'/>"/>

Contact: Emily Ng
eng3@nshs.edu
516-562-2670
North Shore-Long Island Jewish (LIJ) Health System
Source:Eurekalert

Related medicine news :

1. New research finds no association between white potato consumption (baked, boiled mashed) and obesity, Type 2 diabetes or systemic inflammation
2. Novel drug candidates offer new route to controlling inflammation
3. New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
4. Understanding the links between inflammation and chronic disease
5. Study examines chronic inflammation in oral cavity and HPV status of head and neck cancers
6. Childhood adversity increases risk for depression and chronic inflammation
7. Increased cardiovascular risk in HIV-infected patients may relate to arterial inflammation
8. Brigham and Womens Hospital researchers initiate major cardiovascular inflammation reduction trial
9. Targeting inflammation to prevent, treat cancers
10. New genetic risk factor for inflammation identified in African-American women
11. Targeting inflammation to treat depression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... The Ellis Agency, an eastern Georgie ... Foundation in a community wide charity event with the goal of bringing in support ... local woman who lives with epilepsy, recently launched a charity campaign of her own ...
(Date:7/21/2017)... ... July 21, 2017 , ... Fresh Wave® IAQ today announced the launch of ... colleges and universities at the APPA 2017 Annual Conference and Exhibition in ... smoke odors without the use of harsh chemicals, Fresh Wave IAQ Smoke Away Air ...
(Date:7/21/2017)... ... ... The Margarian Law Firm has filed a class action lawsuit against Dr. ... ginger. Dr. Pepper produces the “Canada Dry” brand of ginger ale products. In Gegham ... Ale claims on its bottle that it is made from real ginger. , When ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to regulate ... says Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help ... on Monday, July 21st. , The kit uses colorful, engaging and educational illustrations ...
(Date:7/21/2017)... ... July 21, 2017 , ... ... (ACL) offer patients improved quality of life five years after injury, according to ... Annual Meeting in Toronto, Ontario, Canada. The study followed patients for five years ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... 13, 2017  Centurion Medical Products, a leader in medical product ... fecal impaction removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part ... alleviate patient pain while preventing unneeded emergency department admission due to ...
(Date:7/12/2017)... , July 12, 2017 CarpalAID is a revolutionary new ... or surgery. Carpal tunnel syndrome affects more than 8 ... twice the rate of men. The common methods of treating CTS ... with uncomfortable hand braces or gloves. ... CarpalAID is a clear patch worn ...
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
Breaking Medicine Technology: